Encephalopathy screening: Difference between revisions
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Screening helps in identification of impending encephalopathy or detection of subclinical encephalopathy. Presently strategies for detecting subclinical hepatic encephalopathy and neonatal encephalopathy due to raised bilurubin levels exist. | |||
==Screening== | ==Screening== | ||
Revision as of 13:36, 20 July 2012
|
Encephalopathy |
|
Diagnosis |
|---|
|
Treatment |
|
Encephalopathy screening On the Web |
|
American Roentgen Ray Society Images of Encephalopathy screening |
|
Risk calculators and risk factors for Encephalopathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Screening helps in identification of impending encephalopathy or detection of subclinical encephalopathy. Presently strategies for detecting subclinical hepatic encephalopathy and neonatal encephalopathy due to raised bilurubin levels exist.
Screening
Screening helps in identification of impending encephalopathy or detection of subclinical encephalopathy. Presently strategies for detecting subclinical hepatic encephalopathy and neonatal encephalopathy due to raised bilurubin levels exist.